Compare Nova Ltd (NVMI) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nova Ltd vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nova Ltd trades at $356 (market cap $12.03B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Nova Ltd is far larger — about 5.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals.
| NVMI | SLS | |
|---|---|---|
Market Cap | $12.03B | $2.28B |
Volume | 283,357 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $605.65 | $15.46 |
52-Week Low | $275.78 | $1.39 |
Typical Hold Time | 5 Days | — |
Enterprise Value | $11.82B | $2.15B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
